AFRM vs ALT · P/E 590, rev $3.22B vs rev $20.0K
Affirm Holdings Inc (AFRM) versus Altimmune Inc (ALT) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. ALT currently screens at market cap $527.0M.
Not investment advice. Open the AFRM and ALT stock pages for the full models.
Not investment advice.